Clinical Data Transparency Empowers Financial Process Excellence in the Life Sciences Report Reg Page
[Report] Clinical Data Transparency Empowers Financial Process Excellence in the Life Sciences
Despite years of efforts to simplify and automate site budgeting and payments, several factors have continued to slow progress and drive a fragmented approach to managing trial budgets and interacting with investigators. IDC believes that operational streamlining of financial processes, including investigator payments, will be key to retaining key PIs and making the clinical trial process more sustainable. This IDC Technology Spotlight Report dives into five (5) critical objectives of patient participation and safety. From a data perspective, increased process transparency enables trial managers to:
- more quickly and effectively determine when trial milestones are met;
- identify which sites, if any, need greater attention;
- address drug safety issues in a timely fashion;
- and/or more quickly respond to regulatory issues or reporting as needed.
About IDC Health Insights
IDC Health Insights works with healthcare and life science organizations throughout the world on providing value-based healthcare and knowledge-based medicine. Its global team of analysts with decades of industry experience, advise healthcare organizations how to shift from sick care to healthcare with an emphasis on preventative care and population health management. Health Insights advises life science organizations how to employ a more knowledge-centric approach to new drug development, disease diagnosis, management, and treatment.